You have 9 free searches left this month | for more free features.

bevacizumab

Showing 1 - 25 of 1,129

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Mar 10, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Duarte, California
  • +4 more
Aug 17, 2022

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine plus Bevacizumab
  • Bevacizumab
  • (no location specified)
Jun 30, 2022

Carcinoma, Ovarian Epithelial Trial in Hidaka (pembrolizumab, olaparib, bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • pembrolizumab
  • +5 more
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
Apr 25, 2022

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus

Recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 14, 2021

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer Trial in United States

Recruiting
  • Combined Hepatocellular Carcinoma and Cholangiocarcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Auburn, California
  • +16 more
Aug 17, 2022

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +6 more
  • Balstilimab
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Nov 17, 2022

Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Sep 23, 2022

Advanced Hepatocellular Carcinoma Trial (Adebrelimab, Bevacizumab, SHR-8068)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Jun 30, 2022

Colorectal Cancer, Metastatic Colorectal Cancer Trial (Onvansertib, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • (no location specified)
Oct 20, 2022

Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jul 4, 2022

Brain Injuries Trial in Guangzhou (Bevacizumab)

Recruiting
  • Brain Injuries
  • Bevacizumab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Mar 20, 2022

Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer Trial (DKN-01, FOLFIRI, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • (no location specified)
Jul 28, 2022

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)

Active, not recruiting
  • Sarcoma
  • Bevacizumab
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 6, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Atezolizumab
  • +5 more
  • Phoenix, Arizona
  • +23 more
Aug 24, 2022

Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

Not yet recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Apr 28, 2022

Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

Not yet recruiting
  • Locally Advanced Colorectal Cancer
  • (no location specified)
Oct 18, 2022

Ovarian Cancer Trial in Tai'an (Bevacizumab, chemo, Fluzoparib)

Recruiting
  • Ovarian Cancer
  • Bevacizumab
  • +2 more
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Dec 24, 2021